Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-16
DOI
10.1007/s40265-023-01835-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response
- (2022) Luana Guimaraes de Sousa et al. Journal for ImmunoTherapy of Cancer
- Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma
- (2022) Trisha M. Wise-Draper et al. CLINICAL CANCER RESEARCH
- RATIONALE-309: Updated progression-free survival (PFS), PFS after next line of treatment, and overall survival from a phase 3 double-blind trial of tislelizumab versus placebo, plus chemotherapy, as first-line treatment for recurrent/metastatic nasopharyngeal cancer.
- (2022) Li Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
- (2022) Jimmy J. Caudell et al. Journal of the National Comprehensive Cancer Network
- Results of phase 3 randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer unsuitable for cisplatin-based chemoradiation.
- (2022) Vijay Maruti Patil et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma
- (2022) Ling-Long Tang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
- (2021) Sue S. Yom et al. JOURNAL OF CLINICAL ONCOLOGY
- Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial
- (2021) You-Ping Liu et al. LANCET ONCOLOGY
- Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study
- (2021) Christine H. Chung et al. Cancers
- Characterization of a recombinant gorilla-adenovirus HPV therapeutic vaccine (PRGN-2009)
- (2021) Samuel T. Pellom et al. JCI Insight
- Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial
- (2021) Yasuhisa Hasegawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
- (2021) Alan L. Ho et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
- (2021) Assuntina G Sacco et al. LANCET ONCOLOGY
- Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
- (2021) Nancy Y Lee et al. LANCET ONCOLOGY
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
- (2021) Benjamin Lacas et al. RADIOTHERAPY AND ONCOLOGY
- LBA36 Nivolumab (N) + ipilimumab (I) vs EXTREME as first-line (1L) treatment (tx) for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Final results of CheckMate 651
- (2021) A. Argiris et al. ANNALS OF ONCOLOGY
- 858O Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)
- (2021) A.T. Chan et al. ANNALS OF ONCOLOGY
- Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours
- (2021) Mark R. Middleton et al. BRITISH JOURNAL OF CANCER
- Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study
- (2021) Danny Rischin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II trial of MEDI0457 and durvalumab for patients with recurrent/metastatic HPV-associated cancers.
- (2021) Van K. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- TRYHARD, a randomized phase II trial (RTOG Foundation 3501) of concurrent accelerated radiation plus cisplatin (cis) with or without lapatinib (Lap) for stage III- IV Non-HPV head and neck carcinoma (HNC).
- (2021) Stuart J. Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
- (2021) Yu-Pei Chen et al. LANCET
- Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Yunpeng Yang et al. LANCET ONCOLOGY
- Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
- (2021) Hai-Qiang Mai et al. NATURE MEDICINE
- The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review
- (2021) Kristoffer Juul Nielsen et al. Viruses-Basel
- Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
- (2021) Robert L. Ferris et al. JOURNAL OF CLINICAL ONCOLOGY
- Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery
- (2021) Christopher M. Wright et al. ORAL ONCOLOGY
- Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs
- (2021) Jovian Yu et al. ORAL ONCOLOGY
- Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience
- (2021) Ari J. Rosenberg et al. ORAL ONCOLOGY
- Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
- (2021) Joris L. Vos et al. Nature Communications
- Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors
- (2020) Matthew H. Taylor et al. JOURNAL OF CLINICAL ONCOLOGY
- Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study
- (2020) R.L. Ferris et al. ANNALS OF ONCOLOGY
- Phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck (JCOG1008).
- (2020) Naomi Kiyota et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimization of therapeutic strategy for p16‐positive oropharyngeal squamous cell carcinoma: Multi‐institutional observational study based on the national Head and Neck Cancer Registry of Japan
- (2020) Yuki Saito et al. CANCER
- Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial
- (2020) Ravindra Uppaluri et al. CLINICAL CANCER RESEARCH
- Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) David G. Pfister et al. Journal of the National Comprehensive Cancer Network
- Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study
- (2020) Xu-Shan Sun et al. LANCET ONCOLOGY
- Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas
- (2020) Mara Gilardi et al. MOLECULAR CANCER THERAPEUTICS
- LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
- (2020) J. Bourhis et al. ANNALS OF ONCOLOGY
- B7-H3: an attractive target for antibody-based immunotherapy
- (2020) Filippos Kontos et al. CLINICAL CANCER RESEARCH
- Human papillomavirus oropharynx carcinoma: Aggressive de‐escalation of adjuvant therapy
- (2020) Eric J. Moore et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
- (2020) Maria Gebre-Medhin et al. JOURNAL OF CLINICAL ONCOLOGY
- Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer
- (2020) Renaud Garrel et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
- (2020) Jonathan D. Schoenfeld et al. JAMA Oncology
- Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer
- (2020) Kenneth Emancipator et al. MODERN PATHOLOGY
- Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline
- (2019) Shlomo A. Koyfman et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: A comparative analysis
- (2019) Amr Mohamed et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma
- (2019) Xiao-Yun Li et al. EUROPEAN JOURNAL OF CANCER
- Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma
- (2019) Nicholas C.J. Lee et al. CANCER
- The Emerging Role of Robotic Surgery among Minimally Invasive Surgical Approaches in the Treatment of Hypopharyngeal Carcinoma: Systematic Review and Meta-Analysis
- (2019) Armando De Virgilio et al. Journal of Clinical Medicine
- A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
- (2019) Vijay Maruti Patil et al. CANCER
- Nasopharyngeal carcinoma
- (2019) Yu-Pei Chen et al. LANCET
- Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
- (2019) Yuan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
- (2019) Qi Yang et al. EUROPEAN JOURNAL OF CANCER
- Impact of cisplatin dose and smoking pack-years in human papillomavirus–positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy
- (2019) Marc Oliva et al. EUROPEAN JOURNAL OF CANCER
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort
- (2019) Iain L. Hutchison et al. BRITISH JOURNAL OF CANCER
- Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy
- (2019) Florent Amatore et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
- (2019) Anthony C Nichols et al. LANCET ONCOLOGY
- Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition
- (2019) Joseph A. Miccio et al. ORAL ONCOLOGY
- Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
- (2018) Sarah Yentz et al. BIODRUGS
- Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma
- (2018) Bhishamjit S. Chera et al. CANCER
- Tipifarnib inhibits HRAS-driven dedifferentiated thyroid cancers
- (2018) Brian R. Untch et al. CANCER RESEARCH
- Prognosis of subglottic carcinoma: Is it really worse?
- (2018) Hakan Coskun et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
- (2018) Anthony T.C. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial
- (2018) Yungan Tao et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
- (2018) Lionnel Geoffrois et al. JOURNAL OF CLINICAL ONCOLOGY
- Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
- (2018) Vanita Noronha et al. JOURNAL OF CLINICAL ONCOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
- (2018) K.H. Au et al. ORAL ONCOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Targeting VEGF/VEGFR to Modulate Antitumor Immunity
- (2018) Ju Yang et al. Frontiers in Immunology
- Margins and survival in oral cancer
- (2018) D.A. Mitchell et al. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
- The addition of pretreatment plasma Epstein-Barr virus DNA into the 8th edition of nasopharyngeal cancer TNM stage classification
- (2018) Victor Ho-Fun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
- (2018) Tara C. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison between transoral laser surgery and radiotherapy in the treatment of early glottic cancer: A systematic review and meta-analysis
- (2018) André Vicente Guimarães et al. Scientific Reports
- Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma
- (2018) Rui Guo et al. CANCER
- Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
- (2018) Ezra E W Cohen et al. LANCET
- Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
- (2018) Hisham Mehanna et al. LANCET
- Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
- (2018) Maura L Gillison et al. LANCET
- Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Stage I to II Oral Cavity Cancer
- (2018) John D. Cramer et al. LARYNGOSCOPE
- Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
- (2017) Su-Mei Cao et al. EUROPEAN JOURNAL OF CANCER
- Management of paratracheal lymph nodes in laryngeal cancer with subglottic involvement
- (2017) Marco Lucioni et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Worldwide burden of cancer attributable to HPV by site, country and HPV type
- (2017) Catherine de Martel et al. INTERNATIONAL JOURNAL OF CANCER
- E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
- (2017) Shanthi Marur et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer
- (2017) Daniel M. Trifiletti et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era
- (2017) Ling-Long Tang et al. Journal of the National Comprehensive Cancer Network
- Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
- (2017) Allen M Chen et al. LANCET ONCOLOGY
- Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
- (2017) Li Zhang et al. MOLECULAR CANCER RESEARCH
- Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data
- (2017) Petr Szturz et al. ONCOLOGIST
- High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck
- (2017) Cesar Augusto Perez et al. ORAL ONCOLOGY
- Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy
- (2017) Cheng Xu et al. ORAL ONCOLOGY
- Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer
- (2017) Mark A. Ellis et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
- (2017) Yvonne Y Li et al. Nature Communications
- A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma
- (2017) Zain A. Husain et al. JAMA Oncology
- Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma
- (2017) Lillian L. Siu et al. JAMA Oncology
- Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck
- (2017) et al. Cancers
- The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited
- (2016) Jay S. Cooper et al. CANCER
- Prospective case-control study of efficacy of bilateral selective neck dissection in primary surgical treatment of supraglottic laryngeal cancers with clinically negative cervical findings (N0)
- (2016) V. Djordjevic et al. CLINICAL OTOLARYNGOLOGY
- Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma
- (2016) Anna Spreafico et al. EUROPEAN JOURNAL OF CANCER
- Pattern of lymph node metastasis in hypopharyngeal squamous cell carcinoma and indications for level VI lymph node dissection
- (2016) Eun-Jae Chung et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab
- (2016) David I. Rosenthal et al. JOURNAL OF CLINICAL ONCOLOGY
- Nasopharyngeal carcinoma
- (2016) Melvin L K Chua et al. LANCET
- Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study
- (2016) Brian O'Sullivan et al. LANCET ONCOLOGY
- Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
- (2016) Ying Sun et al. LANCET ONCOLOGY
- Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: a systematic review and meta-analysis
- (2016) Hai-Lan Mo et al. LASERS IN MEDICAL SCIENCE
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole-exome sequencing identifiesMST1Ras a genetic susceptibility gene in nasopharyngeal carcinoma
- (2016) Wei Dai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
- (2016) Hong Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer
- (2016) Ilir Agalliu et al. JAMA Oncology
- Erlotinib and the Risk of Oral Cancer
- (2016) William N. William et al. JAMA Oncology
- Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis
- (2015) N. Gopalakrishna Iyer et al. CANCER
- Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry Phytochemical-Rich Troche
- (2015) T. J. Knobloch et al. Cancer Prevention Research
- Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma – A systematic review of the literature
- (2015) D.H. Yeh et al. EJSO
- Transoral robotic surgery for early T classification hypopharyngeal cancer
- (2015) Chen-Chi Wang et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma
- (2015) Li-Ting Liu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes
- (2015) Arlene A. Forastiere et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
- (2015) Maura L. Gillison et al. JOURNAL OF CLINICAL ONCOLOGY
- Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer
- (2015) Evan J. Wuthrick et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation
- (2015) Guillaume Janoray et al. JNCI-Journal of the National Cancer Institute
- Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
- (2015) Lin-Quan Tang et al. JNCI-Journal of the National Cancer Institute
- Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
- (2015) Pierre Blanchard et al. LANCET ONCOLOGY
- Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
- (2015) Jordi Giralt et al. LANCET ONCOLOGY
- Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial
- (2015) Ricard Mesía et al. LANCET ONCOLOGY
- Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
- (2015) Jean-Pascal H Machiels et al. LANCET ONCOLOGY
- The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients
- (2015) Richard V. Smith et al. LARYNGOSCOPE
- Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer
- (2015) Anil K. D’Cruz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral lesions, chronic diseases and the risk of head and neck cancer
- (2015) Shuang Li et al. ORAL ONCOLOGY
- Subglottic Squamous Cell Carcinoma
- (2015) Emily Marchiano et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Expression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma
- (2015) SHAN-SHAN ZHANG et al. Oncology Letters
- Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma
- (2015) Joseph Zenga et al. JAMA Otolaryngology-Head & Neck Surgery
- Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer
- (2015) Alexander L. Luryi et al. JAMA Otolaryngology-Head & Neck Surgery
- Long-Term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation
- (2015) Guillaume Janoray et al. JNCI-Journal of the National Cancer Institute
- Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
- (2015) Lin-Quan Tang et al. JNCI-Journal of the National Cancer Institute
- The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact
- (2014) G. Mountzios et al. ANNALS OF ONCOLOGY
- Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials
- (2014) A. Argiris et al. ANNALS OF ONCOLOGY
- Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
- (2014) S. F. Leung et al. ANNALS OF ONCOLOGY
- A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck†
- (2014) T. Y. Seiwert et al. ANNALS OF ONCOLOGY
- Predicting survival in head and neck squamous cell carcinoma from TP53 mutation
- (2014) David L. Masica et al. HUMAN GENETICS
- A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: The largest registry-based study to date
- (2014) Emilie Garnaes et al. INTERNATIONAL JOURNAL OF CANCER
- Voice Quality After Treatment of Early Vocal Cord Cancer: A Randomized Trial Comparing Laser Surgery With Radiation Therapy
- (2014) Leena-Maija Aaltonen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
- (2014) Phuc Felix Nguyen-Tan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
- (2014) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners
- (2014) Gypsyamber D'Souza et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma
- (2014) Carole Fakhry et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
- (2014) K. Kian Ang et al. JOURNAL OF CLINICAL ONCOLOGY
- The genomic landscape of nasopharyngeal carcinoma
- (2014) De-Chen Lin et al. NATURE GENETICS
- Etiological factors of nasopharyngeal carcinoma
- (2014) Sai Wah Tsao et al. ORAL ONCOLOGY
- Characterization of HPV and host genome interactions in primary head and neck cancers
- (2014) M. Parfenov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer
- (2014) Kim Wopken et al. RADIOTHERAPY AND ONCOLOGY
- Chemoprevention of oral cancer by topical application of black raspberries on high at-risk mucosa
- (2014) Blake M. Warner et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
- (2013) R. Hitt et al. ANNALS OF ONCOLOGY
- Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer
- (2013) Miriam N. Lango et al. CANCER
- Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer
- (2013) Jeffrey M Vainshtein et al. Expert Review of Anticancer Therapy
- Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: A systematic review
- (2013) John Yoo et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial
- (2013) Renato G. Martins et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
- (2013) Robert Haddad et al. LANCET ONCOLOGY
- Dysplasia at the margin? Investigating the case for subsequent therapy in ‘Low-Risk’ squamous cell carcinoma of the oral tongue
- (2013) Dennis M. Sopka et al. ORAL ONCOLOGY
- Survival Differences between Organ Preservation Surgery and Definitive Radiotherapy in Early Supraglottic Squamous Cell Carcinoma
- (2013) Hassan Arshad et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription
- (2012) I. Brana et al. ANNALS OF ONCOLOGY
- Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors
- (2012) B. J. M. Braakhuis et al. ANNALS OF ONCOLOGY
- Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm
- (2012) Michelle M. Rietbergen et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck
- (2012) Jay S. Cooper et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prevalence of Oral HPV Infection in the United States, 2009-2010
- (2012) Maura L. Gillison et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
- (2012) Arlene A. Forastiere et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term Functional and Oncologic Results of Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
- (2012) Eric J. Moore et al. MAYO CLINIC PROCEEDINGS
- Transoral robotic surgery for hypopharyngeal squamous cell carcinoma: 3-Year oncologic and functional analysis
- (2012) Young Min Park et al. ORAL ONCOLOGY
- TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence
- (2011) H. D. Skinner et al. CLINICAL CANCER RESEARCH
- Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: A united states multicenter study
- (2011) Bruce H. Haughey et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
- (2011) Jochen H Lorch et al. LANCET ONCOLOGY
- Transoral robotic resection and reconstruction for head and neck cancer
- (2011) Eric M. Genden et al. LARYNGOSCOPE
- Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway
- (2010) Kirsten Hannisdal et al. ACTA OTO-LARYNGOLOGICA
- Chemoprevention of Head and Neck Cancer with Green Tea Polyphenols
- (2010) J. W. Kim et al. Cancer Prevention Research
- T1 and T2 hypopharyngeal cancer treatment with laser microsurgery
- (2010) Alexander D. Karatzanis et al. JOURNAL OF SURGICAL ONCOLOGY
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- A prospective study of the clinical impact of a multidisciplinary head and neck tumor board
- (2010) Stephen A. Wheless et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer
- (2009) Robert Haddad et al. CANCER
- Radiotherapy or surgery for head and neck squamous cell cancer
- (2009) Stephen F. Hall et al. CANCER
- Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell Carcinomas
- (2009) T. B.M. Schaaij-Visser et al. CLINICAL CANCER RESEARCH
- Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China
- (2009) Xiuchan Guo et al. INTERNATIONAL JOURNAL OF CANCER
- Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?
- (2009) Anders Näsman et al. INTERNATIONAL JOURNAL OF CANCER
- Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
- (2009) Nancy Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- The Natural History of Patients With Squamous Cell Carcinoma of the Hypopharynx
- (2009) Stephen F. Hall et al. LARYNGOSCOPE
- Organ Preserving Transoral Laser Microsurgery for Cancer of the Hypopharynx
- (2009) Alexios Martin et al. LARYNGOSCOPE
- Open cervical lymph node biopsy for head and neck cancers: any benefit?
- (2009) Adeyi A Adoga et al. Head and Neck Optical Diagnostics Society
- Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
- (2008) V. A. Papadimitrakopoulou et al. CLINICAL CANCER RESEARCH
- Fine-needle aspiration cytology in a regional head and neck cancer center: Comparison with a systematic review and meta-analysis
- (2008) Sankalap Tandon et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management
- (2008) Isaäc van der Waal ORAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started